Transcriptional analysis of the Epstein—Barr virus interleukin-10 homologue during the lytic cycle

References

1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
   [Google Scholar]
2. Giot J.-F., Mikaelian I., Buisson M., Manet E., Joab I., Nicolas J.-C., Sergeant A. 1991; Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Research 19:1251–1258
   [Google Scholar]
3. Hudson G. S., Bankier A. T., Satchwbll S. C., Barrell B. G. 1985; The short unique region of the B95-8 Epstein-Barr virus genome. Virology 147:81–98
   [Google Scholar]
4. Lau R., Middeldorp J., Farell P. J. 1993; Epstein-Barr virus gene expression in oral hairy leukoplakia. Virology 195:463–474
   [Google Scholar]
5. Lotz M., Tsoukas C. D., Fong S., Carson D. A., Vaughan J. H. 1985; Regulation of Epstein-Barr virus infection by recombinant interferons selected sensitivity to interferon-γ . European Journal of Immunology 15:520–525
   [Google Scholar]
6. Moore K. W., O’Garra A., De Waal Malefyt R., Vieira P., Mosmann T. R. 1993; Interleukin-10. Annual Review of Immunology 11:165–90
   [Google Scholar]
7. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Bancherau J. 1992; Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proceedings of the National Academy of Sciences, USA 89:1890–1893
   [Google Scholar]
8. Stewart J. P., Behm F. G., Arrand J. R., Rooney C. M. 1994; Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200:724–732
   [Google Scholar]
9. Takada K., Ono Y. 1989; Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. Journal of Virology 63:445–449
   [Google Scholar]
10. Vieira P., De Waal-Malefyt R., Dang M. N., Johnson K. E., Kastelein R., Fiorentino D. F., Devries J. E., Roncarolo M. G., Mosmann T. R., Moore K. W. 1991; Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFL. Proceedings of the National Academy of Sciences, USA 88:1172–1176
    [Google Scholar]
11. Yates J. L., Warren N., Reisman D., Sugden B. 1984; A cisacting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proceedings of the National Academy of Sciences, USA 81:3806–3810
    [Google Scholar]